Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Abbott Laboratories (NY:ABT)

135.20 -0.35 (-0.26%)
Official Closing Price Updated: 4:10 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
44 45 Next >
Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?
Cardiovascular Systems (CSII) stock is rising higher on Thursday following news that Abbott (ABT) intends to acquire the company. 
Via InvestorPlace
Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M
Via Benzinga
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions
These stocks could boost your portfolio in bear markets and bull markets. 
Via The Motley Fool
Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023?
The healthcare stock fell 22% last year. 
Via The Motley Fool
Is This Dividend King a Buy for Income Investors?
This healthcare company has one of the most established payouts in its sector. 
Via The Motley Fool
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023
You can bet the farm on these companies' dividends. 
Via The Motley Fool
What 5 Analyst Ratings Have To Say About Abbott Laboratories
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
What's Going On With Abbott Laboratories Stock Today?
Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday in the wake of the company's quarterly results. 
Via Benzinga
3 Unstoppable Dividend Stocks to Buy in February
All three belong to the elite group of stocks known as Dividend Kings. 
Via The Motley Fool
2 Top Dividend Growth Stocks to Buy in February
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace. 
Via The Motley Fool
5 Top Stocks to Buy Now
This eclectic mix of stocks will help diversify your portfolio. 
Via The Motley Fool
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
GE Healthcare Technology: Speculating On Dividends
GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one. 
Via MarketBeat
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Overall sales topped forecasts, but organic growth missed expectations. 
Via Investor's Business Daily
A Bullish Sign Appears On Abbott Laboratories's Chart
Via Benzinga
Earnings Outlook For Abbott Laboratories
Via Benzinga
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
At least four Wall Street banks recently raised their price targets for the healthcare giant. 
Via The Motley Fool
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Stocks reacted well to uneven earnings and economic reports. 
Via Investor's Business Daily
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on... 
Via Benzinga
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
There's more to the story than the negative trends for Abbott's top and bottom lines. 
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Why Abbott Laboratories Stock Got Whacked on Wednesday
Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day. 
Via The Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why Aurora Cannabis Stock Is Fading Today
With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today. 
Via The Motley Fool
Abbott Q4 Earnings And Revenues Top Estimates
Abbott came out with quarterly earnings of $1.03 per share. 
Via Talk Markets
Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower
(Wednesday Market Open) The market gives and the market takes away. 
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading: 
Via Benzinga
Investor Optimism Declines Following Earnings Reports
The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings. 
Via Benzinga
Earnings Scheduled For January 25, 2023
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion. 
Via Benzinga
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.